Citations

Clear

4610 citation(s) found for "Lu, Brian".

Strain Dyssynchrony Index Correlates With Improvement in Left Ventricular Volume After Cardiac Resynchronization Therapy Better Than Tissue Velocity Dyssynchrony Indexes
Miyazaki, Chinami , Lin, Grace, Powell, Brian D. , Espinosa, Raúl E. , Miller, Fletcher A., Karon, Barry L., Rea, Robert F., Hayes, David L. , Oh, Jae K. , Bruce, Charles J.

Mayo Clinic

Circulation: Cardiovascular Imaging | July 23, 2008 | Volume: 1 | Issue: 1 | Pages: 14-22

10.1161/circimaging.108.774513 | PMID 19808510 Get It

Background— Various dyssynchrony indexes derived from tissue velocity and strain imaging have been proposed to predict the effectiveness of cardiac resynchronization therapy (CRT). We sought to compare the effect of CRT on dyssynchrony indexes derived by tissue velocity and strain and to determine which baseline intraventricular dyssynchrony parameters correlate with improvement in left ventricular volume after CRT. Methods and Results— Echocardiography with tissue Doppler imaging was performed in 45 patients with systolic heart failure at baseline, 1 day after CRT, and a median of 6 months after CRT. We calculated septal–lateral delay and anteroseptal–posterior delay and standard deviation of time to peak systolic velocity in the 12 basal and mid-left ventricular segments (Tv-SD). The standard deviation for time to peak strain in the 12 basal and mid-left ventricular segments (Tε-SD) was calculated as a strain-derived dyssynchrony index. None of the tissue velocity–derived dyssynchrony indexes improved after CRT (septal–lateral delay, P =0.39; anteroseptal–posterior delay, P =0.46; Tv-SD, P =0.30), whereas Tε-SD decreased significantly after CRT ( P <0.001). Improvement in Tε-SD 1 day after CRT correlated with the reduction in end-systolic volume at follow-up ( r =0.66; P <0.001). Baseline Tε-SD demonstrated significant correlation with the reduction of end-systolic volume at follow-up ( r =0.57; P <0.001); however, baseline tissue velocity–derived dyssynchrony indexes failed to predict the effect of CRT. Conclusions— The strain-derived dyssynchrony index is a better measurement than the tissue velocity dyssynchrony index for monitoring changes in mechanical dyssynchrony after CRT and for predicting reduction in left ventricular volume after CRT.
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
Cady, Francois M., Decker, Paul A. , Kurtz, David M. , Porter, Alyx B. , Kurtin, Paul J. , Johnston, Patrick B. , Remstein, Ellen D., McPhail, Ellen D. , O’Neill, Brian Patrick , Law, Mark E. , Decker, Paul A. , Giannini, Caterina , Doǧan, Ahmet , McPhail, Ellen Darcy , Kurtz, David M

Mayo Clinic

Journal of Clinical Oncology | July 21, 2008 | Volume: 26 | Issue: 29 | Pages: 4814-4819

10.1200/jco.2008.16.1455 | PMID 18645192 Get It

Purpose Primary CNS lymphoma (PCNSL) is an aggressive lymphoma but clinically validated biologic markers that can predict natural history to tailor treatment according to risk are lacking. Several genetic changes including BCL6 rearrangements and deletion of 6q22, containing the putative tumor suppressor gene PTPRK, are potential risk predictors. Herein we determined the prevalence and survival impact of del(6)(q22) and BCL6, immunoglobulin heavy chain (IGH), and MYC gene rearrangements in a large PCNSL cohort treated in a single center. Patients and Methods Interphase fluorescence in situ hybridization was performed using two-color probes for BCL6, MYC, IGH-BCL6, and del(6)(q22) on thin sections of 75 paraffin-embedded samples from 75 HIV-negative, immunocompetent patients newly diagnosed with PCNSL. Survival data were analyzed using Kaplan-Meier survival curves, log-rank tests, and proportional hazards regression adjusting for age, deep structure involvement, and high-dose methotrexate (HDMTX) treatment. Results The prevalence of del(6)(q22) and BCL6, IGH, and MYC translocations was 45%,17%, 13%, and 3%, respectively. The presence of del(6)(q22) and/or a BCL6 translocation was associated with inferior overall survival (OS; P = .0097). The presence of either del(6)(q22) alone or a BCL6 translocation alone was also associated with inferior OS (P = .0087). Univariable results held after adjusting for age, deep structure involvement, and HDMTX. Conclusion Del (6)(q22) and BCL6 rearrangements are common in PCNSL and predict for decreased OS independent of deep structure involvement and HDMTX. Unlike systemic diffuse large B-cell lymphoma, del(6)(q22) is common and IGH translocations are infrequent and usually involve BCL6 rather than BCL2, suggesting a distinct pathogenesis.
18 F-FDG PET in the Management of Patients with Anaplastic Thyroid Carcinoma
Bogsrud, Trond Velde , Karantanis, Dimitrios, Nathan, Mark A., Mullan, Brian P., Wiseman, Gregory A., Kasperbauer, Jan L. , Reading, Carl C., Lowe, Val J. , Hay, Ian

Mayo Clinic

Thyroid® | July 17, 2008 | Volume: 18 | Issue: 7 | Pages: 713-719

10.1089/thy.2007.0350 | PMID 18630999 Get It

Background: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive solid tumors in humans. The use of positron emission tomography (PET) with 18 F-fluorodeoxyglucose ( 18 F-FDG) in ATC has not been studied, and only a few case reports have been published. The objective of this study was to investigate the potential contribution of 18 F-FDG PET to the clinical management of patients with ATC. Methods: All patients with ATC studied with 18 F-FDG PET from August 2001 through March 2007 were included. The PET results were correlated with computed tomography, ultrasound, magnetic resonance imaging, bone scan, histology, and clinical follow-up. The FDG uptake was semiquantified as maximum standard uptake value. Any change in the treatment plan as a direct result of the PET findings as documented in the clinical notes was recorded. Results: Sixteen patients were included. True-positive PET findings were seen for all primary tumors, in all nine patients with lymph node metastases, in five out of eight patients with lung metastases, and in two patients with distant metastases other than lung metastases. In 8 of the 16 patients, the medical records reported a direct impact of the PET findings on the clinical management. Conclusions: ATC demonstrates intense uptake on 18 F-FDG PET images. In 8 of the 16 patients (50%), the medical records reported a direct impact of the PET findings on the management of the patient. PET may improve disease detection and have an impact on the management of patients with ATC relative to other imaging modalities.
Titin Isoforms, Extracellular Matrix, and Global Chamber Remodeling in Experimental Dilated Cardiomyopathy
Jaber, Wissam , Maniu, Calin V., Krysiak, Judith , Shapiro, Brian P. , Meyer, Donna , Linke, Wolfgang A. , Redfield, Margaret M. , Linke, Wolfgang A

Mayo Clinic

Circulation: Heart Failure | June 26, 2008 | Volume: 1 | Issue: 3 | Pages: 192-199

10.1161/circheartfailure.108.768465 | PMID 19808289 Get It

Background— Altered titin isoforms may modify cardiac function in heart failure (HF), but the nature of isoform switches and associated functional implications are not well defined. Limited studies have reported an increased compliant isoform (N2BA) expression in human systolic HF. Titin may also modulate stretch-regulated responses such as myocardial natriuretic peptide production. Methods and Results— We characterized titin isoform expression and extracellular matrix in all 4 cardiac chambers and the left ventricular (LV) epicardium and endocardium in normal dogs (n=6) and those with HF (n=6) due to tachypacing and characterized functional implications at the LV myofiber and chamber level. Recognizing the potential for uncoupling of the extracellular matrix and cardiomyocyte in tachypacing, myocardial natriuretic peptide production, a molecular marker of stretch-regulated responses, was also assessed. All chambers were dilated in HF, but the extracellular matrix was not increased. HF dogs had markedly lower N2BA in the atria and right ventricle. In failing LVs, N2BA was decreased only in the epicardium, where myofiber passive stiffness was increased. However, LV chamber mechanics were driven by the marked LV dilatation, with no increase in LV diastolic stiffness. Natriuretic peptide concentrations increased markedly in the endocardium in relation to increases in LV wall stress. Conclusions— Tachypacing HF is characterized by decreases in compliant titin isoform expression in the atria, right ventricle, and LV epicardium. However, LV chamber mechanics are principally determined by geometric and extracellular matrix changes rather than titin-based myofiber stiffness in this model. Stretch-regulated myocardial responses (natriuretic peptide production) appeared intact, suggesting that the mechanotransduction role of titin was not impaired in HF.
Progenitor Cell Therapy in a Porcine Acute Myocardial Infarction Model Induces Cardiac Hypertrophy, Mediated by Paracrine Secretion of Cardiotrophic Factors Including TGFβ1
Doyle, Brendan, Sorajja, Paul , Hynes, Brian, Kumar, Arun , Araoz, Phillip A., Stalboerger, Paul G., Miller, Dylan V. , Reed, Cynthia , Schmeckpeper, Jeffrey , Wang, Shaohua , Liu, Chunsheng , Krüger, David , Riederer, Stephen J. , Caplice, Noel M. , Sorajja, Paul , Terzic, André

Mayo Clinic

Stem Cells and Development | June 18, 2008 | Volume: 17 | Issue: 5 | Pages: 941-952

10.1089/scd.2007.0214 | PMID 18564032 Get It

Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
French, Amy J. , Sargent, Daniel J. , Burgart, Lawrence J., Foster, Nathan R. , Kabat, Brian, Goldberg, Richard M. , Shepherd, Lois E. , Windschitl, Harold E., Thibodeau, Stephen N. , Sargent, Daniel J

Mayo Clinic

Clinical Cancer Research | June 2, 2008 | Volume: 14 | Issue: 11 | Pages: 3408-3415

10.1158/1078-0432.ccr-07-1489 | PMID 18519771 Get It

Abstract Purpose: Colon tumors with defective DNA mismatch repair (dMMR) have a well-characterized phenotype and accounts for ∼15% to 20% of sporadic colon cancer as well as those colon cancer patients with Lynch syndrome. Although the presence of dMMR seems to be a favorable prognostic marker, data suggest that these patients do not respond as well to adjuvant chemotherapy. Experimental Design: In this study, we examined the prognostic significance of tumor MMR deficiency and the presence of a specific mutation in BRAF (V600E) in a group of patients (n = 533) who participated in a randomized prospective clinical trial through the North Central Cancer Treatment Group. Results: Tumors with dMMR were found to be associated with higher tumor grade (P = 0.001), proximal location (P &lt; 0.0001), and improved overall and disease-free survival (P = 0.05 and 0.04, respectively). Among all cases examined, evaluation of the BRAF V600E mutation status revealed no statistically significant differences in either disease-free or overall survival. Patients were then grouped into four categories for further analysis: dMMR/BRAF(−), dMMR/BRAF(+), pMMR/BRAF(−), and pMMR/BRAF(+). The dMMR/BRAF(−) group had a significantly improved overall survival (5-year overall survival of 100% versus 73%, P = 0.002) compared with all others. The remaining three groups had very similar survival outcomes. An additional cohort of tumors previously classified as having dMMR were also tested for the BRAF V600E alteration. Results remained significant (P = 0.006) when the two groups were combined for analysis. Conclusions: Overall, these data suggest that the underlying molecular etiology of those tumors having dMMR may influence the disease outcome in these patients.
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
Galiè, Nazzareno , Olschewski, Horst , Torres, Fernando, Frost, Adaani , Ghofrani, Hossein Ardeschir , Badesch, David B., McGoon, Michael D., McLaughlin, Vallerie V. , Roecker, Ellen B., Gerber, Michael J., Dufton, Christopher , Rubin, Lewis J. , Oudiz, Ronald J. , Torres, Fernando, McLaughlin, Vallerie V. , Wiens, Brian L. , Olschewski, Horst , Ghofrani, Hossein Ardeschir

Mayo Clinic

Circulation | May 27, 2008 | Volume: 117 | Issue: 23 | Pages: 3010-3019

10.1161/circulationaha.107.742510 | PMID 18506008 Get It

Background— Ambrisentan is a propanoic acid–based, A-selective endothelin receptor antagonist for the once-daily treatment of pulmonary arterial hypertension. Methods and Results— Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study 1 and 2 (ARIES-1 and ARIES-2) were concurrent, double-blind, placebo-controlled studies that randomized 202 and 192 patients with pulmonary arterial hypertension, respectively, to placebo or ambrisentan (ARIES-1, 5 or 10 mg; ARIES-2, 2.5 or 5 mg) orally once daily for 12 weeks. The primary end point for each study was change in 6-minute walk distance from baseline to week 12. Clinical worsening, World Health Organization functional class, Short Form-36 Health Survey score, Borg dyspnea score, and B-type natriuretic peptide plasma concentrations also were assessed. In addition, a long-term extension study was performed. The 6-minute walk distance increased in all ambrisentan groups; mean placebo-corrected treatment effects were 31 m ( P =0.008) and 51 m ( P <0.001) in ARIES-1 for 5 and 10 mg ambrisentan, respectively, and 32 m ( P =0.022) and 59 m ( P <0.001) in ARIES-2 for 2.5 and 5 mg ambrisentan, respectively. Improvements in time to clinical worsening (ARIES-2), World Health Organization functional class (ARIES-1), Short Form-36 score (ARIES-2), Borg dyspnea score (both studies), and B-type natriuretic peptide (both studies) were observed. No patient treated with ambrisentan developed aminotransferase concentrations >3 times the upper limit of normal. In 280 patients completing 48 weeks of treatment with ambrisentan monotherapy, the improvement from baseline in 6-minute walk at 48 weeks was 39 m. Conclusions— Ambrisentan improves exercise capacity in patients with pulmonary arterial hypertension. Improvements were observed for several secondary end points in each of the studies, although statistical significance was more variable. Ambrisentan is well tolerated and is associated with a low risk of aminotransferase abnormalities.
Comparison of Echocardiographic Dyssynchrony Assessment by Tissue Velocity and Strain Imaging in Subjects With or Without Systolic Dysfunction and With or Without Left Bundle-Branch Block
Miyazaki, Chinami , Powell, Brian D. , Espinosa, Raúl E. , Redfield, Margaret M. , Miller, Fletcher A., Hayes, David L. , Cha, Yong‐Mei , Oh, Jae K. , Bruce, Charles J.

Mayo Clinic

Circulation | May 12, 2008 | Volume: 117 | Issue: 20 | Pages: 2617-2625

10.1161/circulationaha.107.733675 | PMID 18474810 Get It

Background— Several echocardiographic dyssynchrony indexes have been proposed to identify responders to cardiac resynchronization therapy using tissue velocity and strain. The present study aimed to compare tissue velocity–derived and strain-derived dyssynchrony indexes in patients with or without systolic dysfunction and left bundle-branch block. Methods and Results— Tissue Doppler imaging was performed in 120 subjects divided into 4 groups: group 1 (n=40), normal subjects; group 2 (n=20), normal left ventricular ejection fraction and left bundle-branch block; group 3 (n=20), left ventricular ejection fraction <35% and normal conduction; and group 4 (n=40), left ventricular ejection fraction <35% and left bundle-branch block. Dyssynchrony indexes based on time to peak tissue velocity (septal-lateral delay, anteroseptal-posterior delay, and SD in time to peak systolic velocity in the 12 left ventricular segments) and strain (SD of time to peak strain in 12 segments) were measured. The SD in time to peak systolic velocity in the 12 left ventricular segments was greater in group 4 (54 ms; 25th and 75th percentiles, 46 to 64 ms) than group 1 (44 ms; 25th and 75th percentiles, 28 to 53 ms; P =0.006), but there was a considerable overlap of all tissue velocity–derived indexes among 4 groups, with 40% to 68% of group 1 having values proposed for predicting the responders of cardiac resynchronization therapy. The SD of time to peak strain in 12 segments distinguished these groups with much less overlap ( P <0.01 for all pairwise comparisons). Conclusions— A substantial proportion of normal subjects have tissue velocity–derived dyssynchrony indexes higher than the cutoff value proposed for predicting beneficial effect of cardiac resynchronization therapy. Strain-derived timing index appears to be more specific for dyssynchrony in patients with systolic dysfunction and left bundle-branch block. Identifying an optimal tissue velocity– or strain-derived dyssynchrony index requires a large prospective clinical trial.
Comparative study of vibro-acoustography and B-mode ultrasound in prostate imaging
Mitri, Farid G., Greenleaf, James F., Alizad, Azra , Davis, Brian J. , Fatemi, Mostafa

Mayo Clinic

The Journal of the Acoustical Society of America | May 12, 2008 | Volume: 123 | Issue: 5_Supplement | Pages: 3788-3788

10.1121/1.2935448 Get It

Vibro-acoustography (VA) is an imaging modality that uses the radiation force of ultrasound to vibrate tissue at a low frequency and records the resulting acoustic field to produce an image that is represents object characteristics at both ultrasound as well as low (audio) frequencies. Currently, B-mode ultrasound is used for prostate imaging. This imaging method has some limitations, including the speckle noise, which limit its ability in detection of lesions and calcifications. The purpose of this study is to explore the potentials of VA for prostate imaging. VA, B-mode ultrasound, and radiography were performed on 12 excised human prostate samples and the resulting images were compared. VA system parameters were, center frequency 3 MHz, Δf=50 kHz, image area 5×5 cm, pixel size 0.2×0.2 mm. Images evaluated in terms of visibility of anatomical and pathological structures and contrast. Results showed that prostate anatomical structures, mass lesions, and calcifications were visible in the VA images taken at different depths, and VA image quality was superior to B-mode. VA images exhibited significant contrast between the central and peripheral zones with enhanced borders. It is concluded that, with further development, VA may become suitable modality for in prostate imaging.